JH Zhang, LL Shan, F Liang, CY Du… - Frontiers in bioengineering …, 2022 - frontiersin.org
Recombinant antibodies are rapidly developing therapeutic agents; approximately 40 novel
antibody molecules enter clinical trials each year, most of which are produced from Chinese …